Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENTA Enanta Pharmaceuticals Inc.

已收盘 02-12 16:00:00 EST

13.84

-0.41

-2.88%

盘后13.84

+0.000.00%

18:02 EST

最高14.38	最低13.82	成交量17.45万
今开14.03	昨收14.25	日振幅3.93%
总市值4.02亿	流通市值2.88亿	总股本2,902万
成交额243.69万	换手率0.84%	流通股本2,083万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENTA","market":"US","secType":"STK","nameCN":"Enanta Pharmaceuticals Inc.","latestPrice":13.84,"timestamp":1770930000000,"preClose":14.25,"halted":0,"volume":174462,"hourTrading":{"tag":"盘后","latestPrice":13.84,"preClose":13.84,"latestTime":"18:02 EST","volume":22738,"amount":314693.92,"timestamp":1770937362719,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.028771929824561414,"floatShares":20830500,"shares":29018522,"eps":-3.087137,"marketStatus":"已收盘","change":-0.41,"latestTime":"02-12 16:00:00 EST","open":14.03,"high":14.38,"low":13.82,"amount":2436934.239822,"amplitude":0.039298,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.087137,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770973200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1363838400000,"exchange":"NASDAQ","adjPreClose":14.25,"postHourTrading":{"tag":"盘后","latestPrice":13.84,"preClose":13.84,"latestTime":"18:02 EST","volume":22738,"amount":314693.92,"timestamp":1770937362719,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.755353,"impliedVol":0.3333,"impliedVolPercentile":0.0956},"requestUrl":"/m/hq/s/ENTA/wiki","defaultTab":"wiki","newsList":[{"id":"1196719366","title":"Enanta制药：有望于2026年第一季度提交EDP-978新药临床试验申请，第四季度公布一期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1196719366","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196719366?lang=zh_cn&edition=full","pubTime":"2026-02-10 05:06","pubTimestamp":1770671184,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals Inc. (ENTA) 近日宣布，其研发管线中的重要候选药物EDP-978正按计划推进。公司预计将在2026年第一季度向监管机构提交新药临床试验（IND）申请，并计划在同年第四季度公布该药物的第一阶段临床研究数据。这一进展标志着EDP-978的研发进程迈入了新的关键阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"1197087685","title":"Enanta Pharmaceuticals公布2025财年第一季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1197087685","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197087685?lang=zh_cn&edition=full","pubTime":"2026-02-10 05:02","pubTimestamp":1770670931,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) 已正式披露其截至2025年12月31日的2025财年第一季度财务报告。该报告详细呈现了公司在报告期内的整体财务表现与关键运营指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2601892678","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601892678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601892678?lang=zh_cn&edition=full","pubTime":"2026-01-06 01:05","pubTimestamp":1767632712,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日01时05分，Enanta Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.27%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.76%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家生物科技公司，采用基于化学的药物发现方法，开发用于病毒学和免疫学应用的小分子候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106010513a49fca14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106010513a49fca14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"1199872058","title":"Enanta Pharmaceuticals公布2025财年第四季度及年度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1199872058","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199872058?lang=zh_cn&edition=full","pubTime":"2025-11-18 05:02","pubTimestamp":1763413356,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals公布2025财年第四季度及年度财务业绩","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"1180755514","title":"Enanta Pharmaceuticals Inc：摩根大通首次覆盖，评级为增持；目标价为17.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180755514","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180755514?lang=zh_cn&edition=full","pubTime":"2025-11-14 13:21","pubTimestamp":1763097677,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals Inc：摩根大通首次覆盖，评级为增持；目标价为17.00美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"1182753525","title":"Enanta Pharmaceuticals宣布完成扩大规模的普通股公开发行，包括承销商完全行使购买额外股份的期权","url":"https://stock-news.laohu8.com/highlight/detail?id=1182753525","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182753525?lang=zh_cn&edition=full","pubTime":"2025-10-03 04:02","pubTimestamp":1759435377,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals宣布已完成扩大规模的普通股公开发行，其中包括承销商完全行使了购买额外股份的期权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2572587779","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572587779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572587779?lang=zh_cn&edition=full","pubTime":"2025-09-30 21:38","pubTimestamp":1759239503,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日21时38分，Enanta Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.05%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213823a44eac8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213823a44eac8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"1164302403","title":"Enanta Pharmaceuticals：研究显示Zelicapavir展现良好安全性且耐受性佳","url":"https://stock-news.laohu8.com/highlight/detail?id=1164302403","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164302403?lang=zh_cn&edition=full","pubTime":"2025-09-29 18:36","pubTimestamp":1759142195,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals：研究显示Zelicapavir展现良好安全性且耐受性佳","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"1143682398","title":"Enanta Pharmaceuticals公布Zelicapavir治疗高风险成人呼吸道合胞病毒(RSV)2B期研究的积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1143682398","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143682398?lang=zh_cn&edition=full","pubTime":"2025-09-29 18:30","pubTimestamp":1759141817,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals发布了其药物Zelicapavir用于治疗高风险成人呼吸道合胞病毒(RSV)的2B期临床试验积极顶线结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"1178392616","title":"Enanta Pharmaceuticals宣布深受爱戴和尊敬的资深首席财务和行政官Paul J. Mellett Jr.逝世","url":"https://stock-news.laohu8.com/highlight/detail?id=1178392616","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178392616?lang=zh_cn&edition=full","pubTime":"2025-09-03 18:04","pubTimestamp":1756893873,"startTime":"0","endTime":"0","summary":"Enanta Pharmaceuticals宣布深受爱戴和尊敬的资深首席财务和行政官Paul J. Mellett Jr.逝世。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2518277610","title":"Enanta Pharmaceuticals, Inc.盘中异动 急速下跌5.12%报6.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277610?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:18","pubTimestamp":1741623535,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时18分，Enanta Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.12%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001855a26a6261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001855a26a6261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2516668835","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668835?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:54","pubTimestamp":1741031659,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时54分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.01%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035420abe68c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304035420abe68c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2514243320","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.71%报7.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514243320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514243320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753050,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.71%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223050a25800a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223050a25800a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2514686416","title":"Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514686416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514686416?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:01","pubTimestamp":1740600098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时01分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.06%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040138963189d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227040138963189d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2514718617","title":"Enanta Pharmaceuticals, Inc.盘中异动 临近午盘急速上涨5.48%报8.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514718617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514718617?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:47","pubTimestamp":1740415634,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时47分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.48%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225004715a2523346&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225004715a2523346&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2512488073","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512488073?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:46","pubTimestamp":1739976378,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时46分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.07%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224618abd501ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224618abd501ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2512519404","title":"Enanta Pharmaceuticals, Inc.盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512519404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512519404?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:31","pubTimestamp":1739910700,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时31分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.04%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190431409627d04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190431409627d04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2511617854","title":"Enanta Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌5.07%报7.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511617854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511617854?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:49","pubTimestamp":1739566144,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时49分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.07%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215044904abcf55fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215044904abcf55fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2511296525","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511296525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511296525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.29%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223113abcdb1ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223113abcdb1ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2510438089","title":"Enanta Pharmaceuticals, Inc.股价飙升10.00% 市值涨1149.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510438089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510438089?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284326,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速上涨10.00%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，利用强大的化学驱动方法和药物发现能力，专注于研发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223206abcb0626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223206abcb0626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","ENTA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enanta.com","stockEarnings":[{"period":"1week","weight":0.0571},{"period":"1month","weight":0.1038},{"period":"3month","weight":0.2159},{"period":"6month","weight":0.7813},{"period":"1year","weight":1.5492},{"period":"ytd","weight":-0.0964}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":-0.0046},{"period":"3month","weight":0.0296},{"period":"6month","weight":0.0754},{"period":"1year","weight":0.1431},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Enanta Pharmaceuticals, Inc.于1995年根据特拉华州法律注册成立。该公司是一家生物技术公司，利用强大的、化学驱动的方法和药物发现能力来发现和开发用于病毒学和免疫学适应症的小分子药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.034398},{"month":2,"riseRate":0.615385,"avgChangeRate":0.072294},{"month":3,"riseRate":0.583333,"avgChangeRate":-0.017985},{"month":4,"riseRate":0.461538,"avgChangeRate":-0.012482},{"month":5,"riseRate":0.384615,"avgChangeRate":-0.05236},{"month":6,"riseRate":0.538462,"avgChangeRate":0.047896},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.006828},{"month":8,"riseRate":0.538462,"avgChangeRate":0.018032},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.007715},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.020104},{"month":11,"riseRate":0.692308,"avgChangeRate":0.077463},{"month":12,"riseRate":0.692308,"avgChangeRate":-0.00172}],"exchange":"NASDAQ","name":"Enanta Pharmaceuticals Inc.","nameEN":"Enanta Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Enanta Pharmaceuticals Inc.,ENTA,Enanta Pharmaceuticals Inc.股票,Enanta Pharmaceuticals Inc.股票老虎,Enanta Pharmaceuticals Inc.股票老虎国际,Enanta Pharmaceuticals Inc.行情,Enanta Pharmaceuticals Inc.股票行情,Enanta Pharmaceuticals Inc.股价,Enanta Pharmaceuticals Inc.股市,Enanta Pharmaceuticals Inc.股票价格,Enanta Pharmaceuticals Inc.股票交易,Enanta Pharmaceuticals Inc.股票购买,Enanta Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}